Navega Therapeutics
San Diego, California, United States · Biotechnology, Health Care, Pharmaceutical · 7 employees
Navega Therapeutics, LLC is a privately-held, early-stage pharmaceutical company developing gene therapy for the treatment of chronic pain associated with rare diseases such as small fiber neuropathy and primary erythromelalgia. Additional programs in the pipeline include a mutation-agnostic approach to treat retinitis pigmentosa and a disease-modifying treatment for rheumatoid arthritis. Our tech
Funding history
- Series seed — $1.3M — Jan 2026
Recent signals
- Jan 30, 2026: Raised $1.3M in Series seed
- Feb 13, 2024: NAVEGA THERAPEUTICS APPOINTS CAROL GREVE-PHILIPS CHIEF BUSINESS OFFICER
See plans & pricing → Track Navega Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.